Clinical trial Recruiting at 1 site Interventional Ages 5 to 17

AI-based model checks how engaged a child is during rehab and how well they move

Official title: AI-based Model for Rehabilitation Engagement and Motor Performance Evaluation in Pediatric Patients

Run by IRCCS Eugenio Medea · NCT07664033 · Data updated 2026-11-12

A small pilot study tests an artificial intelligence tool that helps therapists see in real time how engaged a child is and how they move during therapy using Lokomat or GRAIL.

More Neuromotor Impairments trials

Quick facts

Study typeInterventional
Ages5 Years to 17 Years
SexAll
Enrollment15 (estimated)
SponsorIRCCS Eugenio Medea
Academic / other
Locations1 site (Bosisio Parini)
StatusRecruiting
StartedJune 24, 2026
Main results expectedDecember 31, 2026
Study endsDecember 31, 2026
Registry record updatedNovember 10, 2026
Trial IDNCT07664033 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Children aged 5–17 with neuromotor impairments who are being treated with Lokomat or GRAIL as part of their standard rehabilitation plan and are able to participate in a single 1-hour session.

Probably not a fit

Some participants may not experience a direct benefit from the AI tool if the real-time data are not integrated into therapy or if usability feedback is limited.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This pilot study will enroll 15 pediatric participants aged 5 to 17 with neuromotor impairments, plus at least 5 referring physiotherapists. Each child will undergo a single 1-hour rehabilitation session using Lokomat or GRAIL per their clinical plan, with the AI model providing real-time data on heart rate, engagement, pleasantness, activation, and motor performance to the therapist. After the session, therapists will complete a System Usability Scale questionnaire and offer feedback on the AI tool. The study aims to assess usability and feasibility of the AI-based monitoring model in a pediatric rehabilitation setting. No efficacy endpoints are specified beyond usability and feasibility outcomes.

Why it matters

Potential benefit: If feasible and usable, the AI model could help therapists tailor rehabilitation in real time to a child's engagement and motor responses.

How similar studies have gone: Previous work in rehabilitation technologies has shown potential benefits of real-time monitoring, but this exact AI engagement-monitoring approach in pediatric tech-assisted rehab is exploratory.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Subjects aged between 5 and 17 years with neuromotor impairments who are undergoing rehabilitation therapy using the Lokomat and GRAIL devices, according to the existing clinical plan.

Exclusion Criteria:

* Uncooperative subjects.

Where it's running

  • Scientific Institute IRCCS E.Medea
    Bosisio Parini, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.